Expansion of the lineup with Kanarb complexes… a clinical trial of combining it with Lipitor
Boryung Pharmaceutical is advancing on clinical trials to expand its lineup with the self-developed hypertension treatment ‘Kanarb’ complex.
According to the Ministry of Food and Drug Safety on the 28th, Boryung Pharmaceutical has acquiredan approval to conducta Phase 1 clinical trial for Kanarb...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
